Kiri Industries Limited has informed the Exchange about Investor Presentation
KIRIINDUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kiri Industries filed its Q4-FY25/FY25 earnings presentation detailing both standalone and consolidated numbers. Q4-FY25 consolidated revenue came in at INR 2,050 Mn, up about 19% sequentially, with consolidated EBITDA margin improving sharply by 1,110 basis points year-on-year to 7.2%. Full-year FY25 consolidated revenue rose 4.4% YoY to INR 7,400 Mn, while EBITDA margin improved by 840 basis points to roughly 8%, marking a turnaround from negative territory last year. Standalone numbers remain weak with full-year EBITDA of INR -437 Mn and net loss of INR 1,084 Mn on a consolidated basis, though the bottom line is supported by a INR 3,732 Mn share of profit from associates (up 44.9% YoY). The presentation also updates shareholders on the Singapore Supreme Court-ordered sale of Kiri's 37.57% stake in DyStar Global Holdings to Zhejiang Longsheng for a base consideration of USD 676.26 Mn plus USD 20.29 Mn in additional consideration, with closing targeted by October 2, 2025.
The DyStar stake sale is a major near-term catalyst, potentially unlocking over USD 696 Mn in cash inflows that could meaningfully strengthen the balance sheet and fund growth or debt reduction. However, the standalone dyes and chemicals business continues to post losses, and consolidated profitability remains heavily dependent on associate income, so investors should watch how the company deploys the expected proceeds and whether standalone operations return to profitability.